Skip to content
Home/Companies/Healthcare / Biotech/Sitryx Therapeutics
Sitryx Therapeutics

Sitryx Therapeutics

Healthcare / Biotech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Sitryx Therapeutics?

Sitryx Therapeutics is currently owned by Sofinnova Partners through Sofinnova Capital X (2021 vintage), since 2021. Across its history, Sitryx Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital X · 2021 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorHealthcare / Biotech
Websitewww.sitryx.com

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by SV Health Managers and Sofinnova Partners since 2018.
Co-invest · 2 holders · 2018 · present
SV Health Managers
SV Health ManagersActive
2018 · present(8yr) · SV Life Sciences Fund VI · 2015 · Life Sciences VC
Sofinnova Partners
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Capital X · 2021 · Life Sciences VC

More from Sofinnova Capital X

Other portfolio companies in the same fund.

DISCO Pharmaceuticals
Active
BiotechGermany· 2023
Freya Biosciences
Freya Biosciences
Active
BiotechDenmark· 2023
May Health
May Health
Active
MedTechFrance· 2023
Nuage Therapeutics
Nuage Therapeutics
Active
BiotechSpain· 2023
T-Therapeutics
T-Therapeutics
Active
BiotechUK· 2023
Catamaran Bio
Catamaran Bio
Active
BiotechUS· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Sitryx Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sitryx Therapeutics?

2 strategic and 118financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sitryx Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue